Lower extremity arterial disease
1 paper1 finding
- Humans1
Associations
1SGLT2 inhibitors
upin humans1HR 1.53
1 study
SGLT2 inhibitors
upin humans1HR 1.53
SGLT2 inhibitors raise the risk of lower extremity arterial disease in humans (HR: 1.53).
“Compared to metformin, SGLT2is showed a higher HR for severe LEAD, especially with diastolic blood pressure (dBP) below 80 mmHg (HR: 1.53)”
Humansdiastolic blood pressure below 80 mmHgthree-year
ADA Scientific Sessions 2025 abstract13 Jun 2025
Latest
3 in 12 monthsJournal of Atherosclerosis and Thrombosis
Lipoprotein(a) is Independently Associated with Polyvascular Disease Burden
Cohort study of 1,799 peopleLipoprotein
Angiologiia I Sosudistaia Khirurgiia
Effect of sulodexide on the walking, erectile and cognitive functions based on the findings of the ANDANTE study
Non-randomised trial in 229 peopleInterventions
Journal of Clinical Lipidology
A ≥20% increase in circulating Lp(a) after the commencement of statins, and subsequent risks of atherosclerotic cardiovascular diseases in patients with coronary artery disease
Cohort study of 100 peopleStatins
ADA Scientific Sessions 2025 Abstract
Risk of Severe Lower Extremity Arterial Disease in Elderly Japanese Patients with Type 2 Diabetes—A Propensity Score-Matched Model Analysis of Sodium–Glucose Cotransporter 2 Inhibitors vs. Metformin
Cohort study in peopleSGLT2 inhibitors